Retatrutide Clears Fatty Liver Disease in Over 85% of Patients With Obesity
Findings presented at The Liver Meeting show retatrutide cleared fatty liver disease in more than 85% of patients with obesity, dramatically expanding its therapeutic profile beyond weight loss.